Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Life After the Pandemic: Where do we go from here?
Has COVID-19 affected you or not? What narrative will you construct as time moves forward resulting from the events of recent years? Pausing to examine what you choose to derive is up to each person, but it is essential to know that the more a person decides to choose rather than allow the choice to be made for them, the more they can move forward and beyond. Having lived through a worldwide pandemic means we have all not only survived, but we’ve endured.
Join us for Live Talk; Thursday May 19, 3:00 pm PST
Join us for an informative session when Dr. Lewins Blevins talks about biotin use and its interference in laboratory assays. This week we welcome guest Dr. Saleh Aldasouqi, Professor, and Chief, Division of Endocrinology and Metabolism, and Clinician at Michigan State University Specialty Center, Endocrinology Clinic. "This is definitely something that patients need to know so they can plan discontinuance of the supplement to allow for testing," says Dr. Blevins. You won't want to miss this discussion.
News In Brief
LIVE TALK sessions are now available on Demand. Click here to listen to past shows.
From Recordati Rare Diseases Phase III study confirms the efficacy and safety of ISTURISA®. achieving sustained cortisol control in the majority of patients. Read more
Good news from Amryt Pharma for acromegaly patients in Europe. Read the release from Amryt Pharma on Mycapssa® here.
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify Read more here
Read more about clinical trials from Xeris Pharma, Camurus AB, and Ionis Ph
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Our live talk session from May 12 is now available on-demand with guests Jill Sisco, president of the Acromegaly Community, and Sharmyn McGraw from the Pacific Neuroscience Institute. This was a fascinating perspective on the challenges and opportunities for patient advocacy programs with two of the leading patient advocates in the world of pituitary disease, specifically Cushing's and acromegaly. We talked about the voice of the patient initiatives, support groups, unmet needs, access to medication, and new initiatives to participate in making life better for people dealing with pituitary disease. Don't miss it, and join us next Thursday for another Live Talk session!
A highly informational "live-talk" session from Dr. Blevins. The first segment covers the indications for pituitary surgery for patients with pituitary adenomas. In the second half of the program, he discusses critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.
In session three, we cover the many possible complications from pituitary surgery in terms of pituitary function and the anatomy around the gland. This is a comprehensive review of potential consequences that all pituitary patients, whether they have had, or are about to have surgery, should know and discuss with their surgeons.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsMost Popular Articles
Events
Join us for the 2022 Acromegaly Community Hybrid Educational Conference. May 20-22, 2022 at the Embassy Suites Milpitas, California. More details, and registration here.
The conference is also available virtually! Please watch here to attend and participate live.
